Cancer involves defects in the mechanisms underlying cell proliferation, death and migration. Calcium ions are central to these phenomena, serving as major signalling agents with spatial localization, magnitude and temporal characteristics of calcium signals ultimately determining cell ' 
Introduction
Ca 2þ signalling is imperative for normal cellular behaviour. In non-excitable tissues, it is required for supporting specific cellular function, such as sensation, secretion, absorption, transcellular transport, as well as for maintaining stable tissue homeostasis characterized by balanced cell proliferation, cell death, cell motility, oxygen and nutrient supply. During carcinogenesis, Ca 2þ signalling of some malignant cells is significantly remodelled in a way that compromises normal physiological functions at the same time enabling them to overwhelm normal cells by giving them unconditional advantages for uncontrolled multiplication, evasion of programmed cell death, adaptation to oxygen and nutrients sparse conditions, invasion and spreading beyond the primary tumour site. It would probably be an overstatement to assert that remodelling of Ca 2þ signalling is the prime reason for such transformation in cell's behaviour; it is rather a consequence of dynamic changes in the genome, the influence of epigenetic, environmental factors or adaptive responses that provoke cancer. Nevertheless, as malignant remodelling of Ca 2þ signalling helps to sustain cancer hallmarks, learning its intimate mechanisms and identifying the molecular players involved poses an opportunity for therapeutic halting the progression of certain hallmarks or even reversing them.
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Ca 2þ remodelling in conferring apoptosis resistance
The Ca 2þ -dependence of apoptosis is well defined in numerous original studies and comprehensively illuminated in numerous review articles [2 -5] . It commonly involves initial cytosolic Ca 2þ overload owing to massive entry and/or vast release and can subsequently progress via three largely interrelated and interdependent pathways: mitochondrial, cytoplasmic and ER stress-related (reviewed in [2] [3] [4] [5] 44] An anti-apoptotic role has also been ascribed to the expression of PMCA2 and PMCA4 calcium pumps in breast cancer cells [57, 58, 59] . Interestingly, PMCA2-induced apoptosis resistance is by direct interaction with calcineurin leading to NFAT inhibition and concomitant decrease in NFAT-dependent expression of pro-apoptotic Fas ligand (FasL) [58] , while PMCA4 regulates the NFkB nuclear translocation [59] .
Cancer cell survival can be also enhanced by autophagy, an intracellular self-digestive process that normally maintains the balance between the synthesis, degradation and subsequent recycling of cellular products. In advanced cancer, it participates in selection of the cells with increased tolerance to tumour-specific hypoxia and nutrient deficiency subsequent to disorganized angiogenesis. As a result, metastatic potential and resistance to anti-cancer theray will probably increase.
The IP 3 R calcium release channel of the ER is considered a key player in autophagy [60, 61] . The IP 3 R is known to reside in the ER membranes within ER-mitochondria contact sites and to provide basal constitutive low-level Ca 2þ signalling to sustain mitochondrial Ca 2þ uptake required for efficient mitochondrial respiration and maintenance of normal cell bioenergetics [61] . Blocking IP 3 Rs or suppressing IP 3 production abolishes this signal, leading to lowered ATP production and an increased AMP/ATP ratio which in turn activates AMPK and induces autophagy [62] . Thus, disruption of IP 3 R-mediated ER-mitochondria crosstalk and compromised cell bioenergetics which may take place in advanced cancer under hypoxic and nutrient-deficient conditions may activate autophagy as pro-survival mechanism.
Ca 2þ remodelling in promotion cell migration and metastasis
Metastatic dissemination from the primary tumour site to multiple tissues is the main cause of mortality in cancer. Tumour cells become invasive by acquiring high migratory potential along with the increased ability to degrade extracellular matrix (ECM). Ca 2þ signalling is critical for regulating cell migration and invasion. In malignant cells, it is remodelled in a way that promotes the turnover of focal adhesions, enhances contractile forces and facilitates proteolysis of ECM components [63] . Ca 2þ -dependent regulation of the molecular machinery of migration is provided by calcineurin, CaMKII, proline-rich tyrosine kinase-2 (PYK2), Ca 2þ -dependent protease, calpain, which regulate focal adhesion dynamics and S100 family of EF-hand calcium-binding proteins (especially S100A4) which promotes cell migration via interaction with cytoskeletal proteins, including actin [63] . The links among the expression and function of certain Ca 2þ permeable channels and cancer cells migration, invasion and metastasis are still largely phenomenological, and the mechanisms of their involvement are not fully understood. The following Ca 2þ permeable channels have been implicated in the enhanced migration of various types of cancer cells (figure 3): TRPC1 [64] , TRPM7 [65 -71] , TRPM8 [43, 72, 73] , TRPV1 [74] , TRPV2 [75] , TRPV6 [40] , STIM1 and ORAI1 SOC constituents [13, [76] [77] [78] [79] , some types of VGCCs [35, 80] . Owing to the presence of mechanical stimulusdependent and Mg-ATP-dependent modes of activation TRPM7 was especially implicated in providing spatially restricted Ca 2þ entry in response to local membrane stretch in front of migrating cells [66, 69] as well as promoting m-calpain-mediated disassembly of peripheral adhesions under decreased intracellular Mg-ATP levels [65] typically found in hypoxic tumour conditions. Moreover, high levels of TRPM7 expression per se was established as a prognostic marker for breast cancer [70] and pancreatic ductal adenocarcinoma (PDAC) [71] progression. The presence of TRPM7 was shown to be directly linked to metastasis formation in a mouse xenograft model of human breast cancer [70] and PDAC cell migration [71] . In MDA-MB-231 breast cancer cells, TRPM7 was found to regulate myosin II-based cellular tension, thereby modifying focal adhesion number, cell-cell adhesion and polarized cell movement [70] . High pro-migratory and pro-invasion potentials have been also ascribed to TRPV1, TRPV2, TRPV6 and TRPM8 channels ( figure 3 ). Higher expression of TRPV2 in PCa cells or TRPM8 in squamous cell carcinoma correlated with the induction of MMP-2, MMP-9 and cathepsin B [73, 75] . Using laser capture microdissection of breast tumour tissue, it was established that higher expression of TRPV6 channel tend to localize in the invasive areas, compared with the non-invasive ones, and TRPV6 silencing was able to inhibit migration and invasion of breast cancer cells [40] . However, with respect to TRPV1 channel diverging results have been reported, suggesting that its role in malignant motility and invasion may be cancer cell-specific. Indeed, activation of the TRPV1 channel was shown to promote migration of human hepatoblastoma cells in response to hepatocyte growth factor treatment [74] . On the other hand, in urothelial cancer TRPV1 downregulation rather than enhancement was found to correlate with more aggressive and invasive tumour phenotype suggesting that such downregulation may present an independent negative prognostic factor for bladder cancer patients [81] .
Recently, SOCE and its STIM and ORAI constituents have emerged as important regulators of malignant cell migration (figure 3). Enhanced STIM1-ORAI1-mediated SOCE promoted higher rate of focal adhesion turnover and fast migration of metastatic breast cancer cells via activation of GTPases Ras and Rac [76] and of cervical cancer cells via engagement of calpain and PYK2 [13] . Higher migration of cervical cancer cells owing to STIM1 overexpression was shown to correlate with its accumulation in the ER punctae translocated towards plasma membrane of migratory cells and increasing cytosolic Ca 2þ spikes [78] . This resulted in more effective recruitment and association of active focal adhesion kinase (pTyr397-FAK) and talin at focal adhesions to facilitate force transduction from integrin signalling, and to promote actomyosin formation [78] . Of other Ca 2þ release channels, type 3 IP 3 R (IP 3 R3) was implicated in the invasive behaviours of glioblastoma cells [82] and in the peritoneal dissemination of gastric cancers [29] . IP 3 R3 was shown to be over-expressed in glioblastoma cells, and its pharmacological or siRNA-mediated inhibition suppressed [Ca 2þ ] C increases and migration of glioblastoma cells with IP 3 R3 inhibition by caffeine representing the most effective pharmacological tool [82] . 
Ca 2þ remodelling in tumour vascularization
Vascularization is critical for tumour growth and metastasis. Angiogenesis relies on proliferation and motility of vascular endothelial cells (ECs), which can be activated by diverse extracellular signals. Tumour cells secrete several peptides and growth factors with mitogenic or pro-angiogenic effects on ECs in vitro and in vivo, such as endothelin-1, angiotensin II, basic fibroblast growth factor (bFGF) as well as the vascular endothelial growth factor (VEGF) family of proteins, which are the most potent EC mitogens [84] [85] [86] . These factors can act in a paracrine-type manner owing to their release by tumour and stroma cells as well as in an autocrine fashion on ECs. Intracellular Ca 2þ signals are involved at different critical phases of regulation of the complex process of angiogenesis and tumour progression [87] [88] [89] , and VEGF acts directly on ECs to induce Ca 2þ signalling involving Ca 2þ entry and IP 3 Rmediated release [90] [91] [92] . Carboxyamidotriazole (CAI), an orally active agent with anti-neoplastic and anti-angiogenic activity, is one of the few anti-cancer agents with clear Ca 2þ homeostasis-targeting properties. It is known to act via disruption of Ca 2þ -mediated signal transduction owing to inhibition of non-voltage-operated Ca 2þ channels, which causes suppression of VEGF signalling in ECs, endothelial proliferation and angiogenesis [90] . CAI inhibits [Ca 2þ ] C increases during VEGF-A-induced EC proliferation [90] , consistent with the requirement of Ca 2þ influx for angiogenesis. This agent demonstrated the potential to inhibit tumour cell growth, invasion and metastasis, and clinical trials [93] suggest that it may have utility as a maintenance therapeutic agent for some types of cancer. CAI appeared to be quite specific for SOC channels [94] , which in ECs are composed of STIM1 and ORAI1 proteins [95] . Thus, abnormalities in the expression and/or function of STIM1 and ORAI1, which were shown to mediate VEGFevoked calcium entry promoting EC migration, tube formation and angiogenesis [91] , and might be involved in the enhancing the pro-angiogenic response of ECs in tumours (figure 4). Indeed, upregulated mRNA and protein levels of ORAI1, STIM1 and TRPC1 (which is also known to contribute to SOCE) accompanied by the increase in CAI-sensitive SOCE were detected in endothelial progenitor cells from patients with renal cellular carcinoma [96] .
A number of the TRP-channel family members are expressed in ECs contributing the angiogenic process by providing agonist-or mechanical stretch-induced Ca 2þ entry [85, 88, 97] (figure 4). In particular, TRPC1 and TRPC4 channels, which exhibit a store-dependent mode of gating, have been implicated The involvement of diacylaglycerol-gated TRPC3 or TRPC6 was implicated in VEGF-induced permeability of microvascular ECs [98, 99] . ECs also express members of TRP family (TRPM and TRPV), as well as STIM and ORAI involved in different aspects of malignant pro-angiogenic behaviours such as EC proliferation, migration and permeability [88, 89, 97] (figure 4). In addition to directly promoting EC proliferation, migration and permeability, Ca 2þ influx through TRPs might stimulate ECs to produce and release the angiogenic growth factors VEGF, FGF and PDGF, which in turn might stimulate angiogenesis in an autocrine or paracrine manner (figure 4). It was also shown that Ca 2þ influx through the reverse mode of the NCX1 Na þ /Ca 2þ exchanger is required for VEGF-induced ERK1/2 phosphorylation and downstream EC functions in angiogenesis [100] .
Clinical prospects
Despite significant achievements in understanding remodelling of Ca 2þ signalling in cancer progression and cancer hallmarks, the practical utility of these findings for clinicians still remains very limited [101] . Given the ubiquity of the Ca 2þ handling toolkit and its involvement in the physiological activity of normal cells, selective targeting of its components in cancer cells presents the major challenge. Despite the existence of numerous pharmacological and molecular biological research tools for targeting Ca 2þ transport proteins with the purpose of reducing or reversing malignant behaviours of cancer cells in in vitro conditions with some of them even demonstrating profound anti-neoplastic effects in in vivo animal models, because of poor specificity, significant adverse effects and/or problems with selective delivery these research tools cannot be used clinically. In addition to the prospective clinical tools and strategies described before [101] , recently synthetic vanilloids were proposed as therapeutics for high-grade astrocytoma [52] . By activating the ER-localized TRPV1 channel, which is significantly over-expressed in this type of cancer cell, they induce ER-stress thereby promoting tumour cell death [52] to be a promising approach for cancer treatment. One of the realizations of this approach is based on using SERCA pump inhibitors from plant-derived sesquiterpene lactones and their derivatives which promote Ca 2þ -dependent apoptosis by preventing ER Ca 2þ uptake [102] . As systemic administration of these compounds can produce significant toxicity to normal cells, to enable their use for PCa treatment it was proposed that they should be combined with a targeting peptide representing the substrate for prostate cancer-specific serine protease, prostate-specific antigen [103] .
Conclusion
Remodelling 
